SLC7A5 and prostate neoplasm: We hypothesize that the decrease in serum BCAAs levels could result from higher BCAAs uptake through the L-type amino acid transporter LAT1 (SLC7A5), which is highly expressed in prostate tumor tissues [51], and the subsequent catabolism of BCAAs for energy production by PC cells.